HomeALCOX • EPA
add
NicOx SA
Previous close
€0.30
Day range
€0.30 - €0.32
Year range
€0.14 - €0.49
Market cap
21.11M EUR
Avg Volume
200.70K
P/E ratio
-
Dividend yield
-
Primary exchange
EPA
Market news
Investopedia
1 hour ago
S&P 500 Gains and Losses Today: Eli Lilly Stock Falls as Sales Outlook
Weakens
0.11%
Financials
Income Statement
Revenue
Net income
| (EUR) | Jun 2023info | Y/Y change |
|---|---|---|
Revenue | 866.50K | — |
Operating expense | 1.75M | — |
Net income | -3.30M | — |
Net profit margin | -381.19 | — |
Earnings per share | — | — |
EBITDA | -4.17M | — |
Effective tax rate | -0.30% | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Jun 2023info | Y/Y change |
|---|---|---|
Cash and short-term investments | 19.01M | — |
Total assets | 82.28M | — |
Total liabilities | 36.75M | — |
Total equity | 45.53M | — |
Shares outstanding | 50.15M | — |
Price to book | 0.33 | — |
Return on assets | -12.84% | — |
Return on capital | -15.84% | — |
Cash Flow
Net change in cash
| (EUR) | Jun 2023info | Y/Y change |
|---|---|---|
Net income | -3.30M | — |
Cash from operations | -4.16M | — |
Cash from investing | -19.50K | — |
Cash from financing | -135.00K | — |
Net change in cash | -4.32M | — |
Free cash flow | -2.86M | — |
About
Nicox S.A. is a French ophthalmology company developing treatments to maintain vision and improve ocular health. Nicox is headquartered in Sophia Antipolis, France, and its Chairman and CEO is Michele Garufi.
Nicox is listed on Euronext Paris and is part of the CAC Healthcare, CAC Pharma & Bio and Next 150 indexes. Its pipeline includes three programs in development, and it has two U.S. Food and Drug Administration approved products. Wikipedia
Founded
1996
Headquarters
Website
Employees
5
